Local Recurrence Rates are Low in High-Risk Neoadjuvant Breast Cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657)

BACKGROUND: Increasingly, women with stage 2 and 3 breast cancers receive neoadjuvant therapy, after which many are eligible for breast-conserving surgery (BCS). The question often arises as to whether BCS, if achievable, provides adequate local control. We report the results of local recurrence (LR...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ann Surg Oncol
Hauptverfasser: Cureton, Elizabeth L., Yau, Christina, Alvarado, Michael D., Krontiras, Helen, Ollila, David W., Ewing, Cheryl A., Monnier, Sindy, Esserman, Laura J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2014
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4303244/
https://ncbi.nlm.nih.gov/pubmed/24788555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-014-3721-7
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge